Howard E. Greene Jr. is Director at AMYLIN PHARMACEUTICALS INC (AMLN). They have made 6 open-market trades across 2 companies since 2006, most recently 2019-08-05.
CIK 0000903574
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $100K since 2018, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TNDM | SELL | 2019-08-05 | 2019-08-06 | $61.47 | $1.1M | -4.8% | +13.3% | +1.4% |
| TNDM | SELL | 2019-02-28 | 2019-03-01 | $65.59 | $1.2M | +4.6% | -12.3% | +1.3% |
| TNDM | SELL | 2018-11-06 | 2018-11-07 | $36.53 | $861K | -23.8% | -15.1% | +10.3% |
| TNDM | BUY | 2018-02-09 | 2018-02-13 | $2.00 | $100K | +20.2% | +49.6% | +332.0% |
| TNDM | SELL | 2015-08-03 | 2015-08-04 | $12.70 | $254K | -64.7% | -22.0% | -22.0% |
| AMLN | SELL · 10b5-1 | 2008-02-19 | 2008-02-20 | $28.74 | $106K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2008-02-04 | 2008-02-05 | $32.08 | $119K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2008-01-22 | 2008-01-24 | $33.08 | $122K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2008-01-07 | 2008-01-09 | $35.55 | $132K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-12-24 | 2007-12-26 | $38.23 | $141K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-12-10 | 2007-12-12 | $39.05 | $144K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-11-26 | 2007-11-27 | $39.05 | $144K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-11-12 | 2007-11-13 | $40.44 | $150K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-10-29 | 2007-10-31 | $46.46 | $172K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-10-15 | 2007-10-17 | $47.90 | $177K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-10-01 | 2007-10-02 | $49.54 | $183K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-09-17 | 2007-09-18 | $47.88 | $177K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-09-04 | 2007-09-06 | $49.50 | $183K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-08-20 | 2007-08-21 | $48.92 | $181K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-08-06 | 2007-08-07 | $48.67 | $187K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-07-23 | 2007-07-24 | $43.34 | $167K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-07-09 | 2007-07-10 | $42.33 | $163K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-06-25 | 2007-06-25 | $41.34 | $159K | N/A | N/A | N/A |
| AMLN | SELL · 10b5-1 | 2007-06-11 | 2007-06-12 | $41.46 | $159K | N/A | N/A | N/A |
| BSTE | SELL · 10b5-1 | 2007-06-04 | 2007-06-04 | $91.98 | $115K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.